logo
Investors warming up to build-to-rent

Investors warming up to build-to-rent

Yahoo05-06-2025

This story was originally published on Multifamily Dive. To receive daily news and insights, subscribe to our free daily Multifamily Dive newsletter.
Following a string of successful years, the build-to-rent sector has maintained its frenzied activity pace through 2024 and into 2025. A significant amount of new build-to-rent supply has come online in the past 12 months, according to Jordan LaMarche, vice president of Bethesda, Maryland-based real estate consultancy RCLCO — a trend likely to continue for the next six months.
Still, despite 2024 representing the peak of new supply, BTR still makes up only 6%-7% of total rental deliveries. 'We … think this is still very short of the potential demand for the product type overall,' La Marche said during a recent RCLCO webinar on the current state of the BTR market.
Given this increase in supply, rent growth has been stagnant in BTR year over year, according to LaMarche. However, BTR has a 0.5% higher occupancy rate than multifamily overall, and weakening starts may lead to declining vacancies over the course of the year, according to LaMarche.
While build-to-rent is still a newer asset class, investors have a greater understanding of BTR and their exposure to it than they did in the past, and are trying to figure out where it fits in their portfolio, according to Rick Pollack, managing director of RCLCO Fund Advisors.
'They really want to understand the fundamentals of how it works,' Pollack said. 'How does it lease? How does it operate? How can they be smarter about their investments going forward … [and] what does the end of the investment look like?'
LaMarche noted that even within the confines of a single-family rental home or townhome, developers are experimenting with product type and how different features might appeal to customers or reduce costs. For instance, even within the same submarket, two BTR properties may vary widely in terms of style, unit size and garage arrangement.
'There isn't a silver bullet yet to get the exact right renter segmentation,' LaMarche said. 'But there is plenty of room for customization to potentially meet higher price points.'
Pollack believes that the sector is in 'the second to third inning' of its development, but will need more time to mature completely. Currently, there are very few transactions in the BTR sector for investors to build their predictions on; as more occur, more players may enter the space as they get a better idea of the numbers involved.
'From the institutional investor standpoint, [what] gets us further along in the game is more stabilized communities and more stabilized communities that trade,' Pollack said. 'A lot of the capital market space is based on core transactions and then folks adjust their risk and return expectations on core transactions.'
Based on interactions with owners and investors, LaMarche's suggestions for the single-family rental sector include:
Investing in the education and marketing processes early. Because build-to-rent is a relatively small product type, renters, investors and municipalities often need more information on what it is and how it works, especially in new markets.
Know your demographics. Cottage-style homes tend to attract older residents or those without children, while townhomes appeal more to families.
Be strategic about amenities. Pools, fitness centers and dog parks are very valuable to renters — 'but stop there,' LaMarche said. 'Other amenities don't drive a significant premium and smaller versions do just as well as the larger ones.'
Prioritize delivering amenities with the first units, in order to attract renters. However, limit the first residents' exposure to construction as much as possible.
Add fences to yards. Regardless of yard size, fenced yards drive a high rent premium as spaces for kids and pets.
Size driveways and garages for larger cars. Since many single-family renters are young families, they may have larger cars than the average renter and will value easy parking.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

Business Wire

timean hour ago

  • Business Wire

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

BASEL, Switzerland--(BUSINESS WIRE)--Syngenta is accelerating the rollout of its nature-inspired, science-based biological solutions, responding to rising demand for sustainable, high-performance tools that help farmers boost productivity efficiently and responsibly. It also contributes toward Syngenta's fulfilment of commitments outlined in its Sustainability Priorities. Jonathan Brown, Global Head Biologicals & Seedcare, comments: 'With our recent partnerships and acquisitions and extended manufacturing capacities, Syngenta is positioning itself as the leader in biologicals. Our scientific expertise is at the forefront of our research and development efforts to provide farmers with the next generation of biologicals, helping them transition towards more sustainable farming practices, such as regenerative agriculture.' In December 2024, the company acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient-use efficiency products. Most recently, in early 2025, Syngenta concluded the integration of Novartis' Strains and Natural Products Collection, the repository of natural compounds and genetic strains for agricultural use. These additions will accelerate the development of biologicals, bringing new tools to the market as a sustainable complement to conventional crop protection solutions. Also in 2025, Syngenta opened a 22,000 m² biologicals facility in Orangeburg, South Carolina, in the United States, which is purpose-built to produce 16,000 tons of biostimulants annually. This new manufacturing facility complements Syngenta's existing global network of biologicals' manufacturing facilities in Brazil, Italy, India and Norway. These strategic milestones effectively enhance both Syngenta's R&D, operating out of the centers of excellence in Stein, Switzerland; Jealott's Hill, UK; Atessa, Italy; and production capacity for biologicals, facilitating Syngenta's roll out of its biologicals pipeline, with multiple candidates demonstrating strong commercial potential with projected annual sales above USD 100 million. Syngenta Biologicals posted strong Q1 2025 results, with standout performance in North America and China. The global biologicals market is growing at around 10% CAGR and is projected to reach nearly USD 20 billion by 2030, according to AgbioInvestor and Syngenta's estimate, underlining the pivotal role of biologicals in the future of sustainable farming. Derived predominantly from naturally occurring substances, biologicals offer significant potential for sustainable agriculture. The market can be categorized into three main categories: Biocontrols – Naturally derived products for managing pests, diseases, and weeds. Biostimulants – Products enhancing natural plant processes to improve abiotic stress tolerance and crop quality. Nutrient Use Efficiency (NUE) products – Any substance or microorganism to improve macro- and micronutrient availability and uptake to promote growth and enhance yield. About Syngenta Syngenta is a global leader in agricultural innovation with a presence in more than 90 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world's population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X. Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ('legitimate interest'). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement. Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors. ©2025 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.

Lululemon is accusing Costco of ripping off its chinos and yoga jackets
Lululemon is accusing Costco of ripping off its chinos and yoga jackets

Business Insider

timean hour ago

  • Business Insider

Lululemon is accusing Costco of ripping off its chinos and yoga jackets

Lululemon is going after Costco, saying it copied the designs of some of its most popular product lines. The Vancouver-based athleisure brand filed a lawsuit against Costco on Friday in California court, accusing it of ripping off the designs of its yoga jackets and chinos. In the 49-page filing, it spotlighted three product lines — its Scuba hoodies and sweatshirts, Define jackets, and ABC pants — saying Costco had created "confusingly similar" dupes of them. It said Costco had infringed its "trade dress," a broad trademark law that protects the look and feel of a product. In the lawsuit, Lululemon put pictures of Costco's and its products side by side in tables to emphasize design similarities. For example, it compared Costco's Kirkland men's pants, priced at $19.90, to the $128 ABC men's pants. It also compared Costco's Spyder women's yoga jacket, which retails for $21.90, to the Lululemon Define jacket, which retails for $128. "There is even a hashtag 'LululemonDupes' on social media platforms such as TikTok that social media influencers use when promoting these copycat products," Lululemon said in the filing. "The Infringing Products create an improper association with Plaintiffs' authentic products." Per the filing, Lululemon said it wanted damages from Costco in the form of lost profits and compensation for patent infringement. It also wants Costco to stop manufacturing and selling more products that are "identical or confusingly similar" to Lululemon's clothing. Costco has yet to respond to Lululemon's lawsuit. Representatives for Lululemon and Costco did not respond to requests for comment from Business Insider. Lululemon has accused other companies of copyright infringement. In 2021, the brand sued exercise equipment company Peloton after it launched its clothing line. Lululemon used similar wording in that lawsuit, saying Peloton's products looked "confusingly similar" to its own Align leggings. The two companies settled the lawsuit in September 2022. In 2012, Lululemon sued Calvin Klein, saying the latter infringed design patents on its now-discontinued "Astro" yoga pants' signature waistband and design. However, it withdrew the lawsuit in the same year after the parties agreed to a confidential settlement.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store